BKD Earnings

BKD reported its earnings on 2026-02-18, showcasing a revenue of 754.09M against an estimate of 770.48M, resulting in a -2.13% surprise. The EPS was -0.17, surpassing the expected -0.16 by -6.25%. The stock experienced a -9.72% price change on the earnings day and a -7.25% change over the next five days, reflecting market reactions to the results.

Following BKD's earnings announcement on 2026-02-18, the stock price moved by -9.72% on the day of the release. Over the subsequent five days, it saw a -7.25% change. Historically, BKD's stock price tends to shift by an average of -6.28% in the 10 days leading up to earnings and 2.36% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate BKD's annual revenue to reach 757.77M, while the EPS is projected at -0.08. These estimates reflect recent revisions, with revenue estimates revised downward by -0.02% and EPS estimates revised downward by -0.08% over the past three months, indicating analyst expectation in the company's performance.

The correlation between BKD's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised downward by -0.02%, while EPS estimates moved revised downward by -0.08%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BKD's stock price typically moves by -6.28% in the 10 days before its earnings and 2.36% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.08 and revenue of 757.77M.

The earnings call reveals strong financial performance with a 19% increase in EBITDA, improved occupancy, and positive RevPAR growth. Despite missing free cash flow guidance, the company shows progress in leverage reduction and resident satisfaction. The Q&A highlights strategic initiatives like HealthPlus expansion and a centralized pricing strategy, which bolster growth prospects. While some guidance details were vague, overall sentiment is positive with raised EBITDA guidance, occupancy gains, and strategic focus on operational efficiency. Given the market cap, a positive stock price reaction of 2% to 8% is expected over the next two weeks.